Diversify Wealth Management’s AbbVie ABBV Stock Holding History

Diversify Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$257	Hold	100	–	–	﹤0.01%	1268
2026 Q1	$204	Buy	+100	New	+$22.2K	﹤0.01%	1162

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Diversify Wealth Management's ABBV Position: Q2 2026 in Review

Diversify Wealth Management increased its AbbVie (ABBV) stake by 0.98% in Q2 2026, buying an estimated $136K and bringing the position to 64,821 shares worth $16.7M. The position accounts for 0.28% of the portfolio, ranked #72.

Diversify Wealth Management first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Diversify Wealth Management held 64,821 shares of AbbVie worth $16.7M as of Q2 2026.
Diversify Wealth Management bought 631 AbbVie shares in Q2 2026, an estimated $136K.
AbbVie made up 0.28% of Diversify Wealth Management's portfolio in Q2 2026, its #72 holding.
Diversify Wealth Management first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Diversify Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.